Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR) Investor Investigation Focuses on Wrongdoing Allegations
An investigation for current investors in NASDAQ:OPTR shares over potential breaches of fiduciary duties by certain directors of Optimer Pharmaceuticals, Inc. was announced and current NASDAQ:OPTR stockholders should contact the Shareholders Foundation.
View full press release